DNA Communications, part of The Weber Shandwick Collective, has launched a health education communications offering in the U.S. called the DNA Medical Education Center, effective immediately. 

The U.K. version of the center has been in place since the agency’s creation in 2011, DNA president Mike Rosich said. The agency saw an opportunity in North America to scale the offer marketwise, but also offer clients located in the U.S. a team that’s on the ground and in their timezone. 

“For clients, it’s to help them be able to tell their story to the right audience in the right way,” Rosich said, noting that the expanded U.S. offer allows DNA to lean heavier into harder science and a technical HCP audience, while ensuring they’re approaching it from an end-to-end communications perspective for an investor, employee or patient. 

“[We’re] looking at it as we are storytellers and scientific storytellers at the core, and making sure that we can do all the types of storytelling that our clients want,” he added.

The new offering will bring scientific storytelling capabilities to the process of educating healthcare providers on medical information, the agency said in a statement. 

Ben King, previously a VP based in DNA’s London office, relocated to the U.S. earlier this year to launch the offering. King has been promoted to SVP and will oversee the continued evolution of the U.S.-based DNA Medical Education Center in partnership with EVP of scientific communications Nikki LeBrasseur. 

A team of about 70 people in North America is working across the medical education team in different capacities, including writers, creatives, experiential and social practitioners.

“We have seen significant and growing demand for DNA’s capabilities in North America, resulting in substantial year-over-year growth,” Weber Shandwick North America CEO Jim O’Leary said. “Launching this doubles down on what clients have come to value from our team as they face an increasingly complex set of challenges.”

The work, which was piloted in the U.S. last year with projects for clients Pfizer and NS Pharma, covers pharmaceutical products, medical devices and the latest understanding of the biological underpinnings of human diseases. DNA has expanded its work with both clients this year, Rosich said. 

As the offering continues to grow, it will assist pharmaceutical and medical device manufacturers in creating narratives and engaging content for new products and solutions, according to the agency. 

DNA Communications is a member agency of The Weber Shandwick Collective. The Interpublic Group network of firms also includes comms shops Cappuccino, Current Global, KRC Research, Flipside, Powell Tate, Prime, Resolute, That Lot, United Minds and Weber Shandwick. 

The Weber Shandwick Collective reported a revenue increase of 6% to $970 million globally and $580 million in the U.S. in 2023, according to PRWeek’s 2024 Agency Business Report. 

This article originally appeared on PRWeek US.